A retrospective, observational study to investigate the therapeutic value of dexmedetomidine (dexdor®) in clinical practice (DexBOS)

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Other
• If ‘other’, further details on the scope of the study:
  Therapeutic use
• Data collection methods:
  Secondary use of data

Non-interventional study

• Non-interventional study design:
  Case-control

Population studied

• Short description of the study population:
  Patients who have been treated with dexdor since it's introduction to the study sites.
• Age groups:
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Estimated number of subjects:
  200

Study design details

• Main study objective:
  To investigate the therapeutic value of Dexdor in clinical practice in Belgium compared with matched control patients who received standard care.
• Data analysis plan:
  To investigate the therapeutic value of Dexdor compared with matched historical controls.